News & Events

Stay up-to-date on all of Cook Regentec news and information
January 22-25, 2019
Phacilitate Leaders World and the World Stem Cell Summit
Miami, FL USA
Visit site
26 February - 1 March 2019
Cell Therapy Manufacturing Asia 2019
Tokyo, Japan
Visit site
May 29 - June 1, 2019
ISCT 2019
Melbourne, Australia
Booth # 54,55,56
Visit site
November 6-10, 2019
SITC 2019
National Harbor, MD USA
Booth #540
Visit site

Qasim RafiqFree Webinar
June 20, 2017
Why are we still using FBS in our processes?
Hosted by RegMedNet in association with Cook Regentec LIVE event via webcam: Tuesday, June 20
Speaker: Dr. Qasim Rafiq, Associate Professor at University of College London

WATCH NOW ON DEMAND!

Free Webinar
March 16, 2017
Induced pluripotent stem cells (iPS) derived from patients with known genetic disease for modeling disease progression in vitro
Featuring: Jason S. Meyer, PhD, Associate Professor Biology, (Indiana University Purdue University)
Read Transcript

Free Webinar
December 15, 2015
Pooled human platelet lysate: a viable alternative to FBS for 2D and 3D culture of mesenchymal stem cells
Featuring: Thomas Heathman, PhD researcher (Loughborough University)

Presentation
May 17-19, 2017
Cellular Therapeutics in Trauma and Critical Care (CTTACC)
Presentation: Establishing Platelet Lysate as a Dependable Option for Enabling Cell Production
Speaker: Brad King, Director of Advanced Laboratory Products
View presentation

May 3-6, 2017
Cook Regentec at ISCT 2017
View our 2017 ISCT Posters; and See Cook Regentec’s booth in RegMedNet’s video conference report

Oct 26, 2018
Cook Regentec Celebrates Opening of Indianapolis Facility, Announces Collaboration with Indiana University School of Medicine
Collaboration aimed at developing tools and technologies that advance solutions in immunotherapy, precision medicine, drug delivery, regenerative medicine and bioprinting. Read More

Oct 26, 2018
Cook Regentec collaborates with Indiana University School of Medicine to develop new technologies.
Cook Regentec, Cook Group’s first company in Indianapolis, announced a collaboration with Indiana University School of Medicine. Read More

Oct 26, 2018
New Cook Regentec Facility to House The Collaboratory
The Collaboratory is an innovation partnership between Cook Regentec and the Indiana University School of Medicine. Watch the video

Oct 30, 2018
Cook Group transforms Indy beer warehouse into modern research site
Not long ago an old dilapidated industrial warehouse was transformed by Cook into a modern facility to develop tools and technology for regenerative medicine, immunotherapy and bioprinting. Read More

Oct 24, 2018
Cook Regentec Opens New Indianapolis Facility
WTHR, local NBC affiliate Channel 13, covered the ribbon cutting for the new Cook Regentec building in the 16 Tech Innovation District. Watch Video

  • September 11, 2019
    First Patient Enrolled in Cook Regentec’s Clinical Trial of Investigational Therapy for Critical Limb Ischemia
  • September 9, 2019
    Sexton Biotechnologies to pursue commercialization of cell and gene therapy bioproduction tools
  • March 27, 2019
    Cook® Regentec Launches ProFusion Therapeutic Infusion Needle for Intramuscular or Subdermal Infusion of Therapeutic Agents
  • July 18, 2018
    Cook Regentec Announces First U.S. Clinical Use of Advance® CS Coronary Sinus Infusion Catheter to deliver a therapeutic in heart failure patients

April 13, 2017
National Heart, Lung, and Blood Institute (NHLBI)
NHLBI Small Business program supported development of new stem cell preservation technologies Stem cell preservation enables advances in regenerative medicine. Read more

March 1, 2017
A deeper look @UIndy – UIndy Blog
Molly (Busenbark) took her M.A. in History to Cook Regentec As part of her studies in the M.A. in History program at the University of Indianapolis, Molly Busenbark completed her thesis on naval mutinies during WWI. The 2006 graduate now works as a Quality Assurance Specialist at Cook Regentec. Read more

March 2017
Biofutures, page 23
Cook Group boosts 16 tech campus $16.5M Indy expansion in works. Read more

November 29, 2016
Introducing the CellSeal Automated Thawing System
Cook Regentec and Asymptote announced today the commercial launch of the CellSeal Automated Thawing System for effective, fully automated thawing in lab. Please read the press release for further information.

November 16, 2016
Cook Group plans $16.5M local expansion, 82 jobs
Bloomington-based Cook Group Inc. plans to spend about $16.5 million to expand its medical research and development facility in Indianapolis in a project that could create 82 jobs over the next five years. Read more

November 13, 2016
Seattle Children’s Hospital
Erin’s Journey to Becoming Cancer-Free Through Seattle Children’s T-Cell Immunotherapy Trial
CellSeal vial used in Seattle Children’s Hospital T-Cell Immotherapy Trial treating six-year-old Erin Cross of Chester, England. Watch interview

March 5, 2018
Cook Regentec e-Newsletter
IT’S POSTED! <1% Variation in Fill Accuracy for SAFS-100 CellSeal® Semi-Automated Filling System. Read more

September 25, 2017
Cook Regentec e-Newsletter
2 Reasons to Try HPL. From Dr. Rafiq’s studies: 75% increase in yield & 20-hour reduction in doubling time. Read more

May 11, 2017
Cook Regentec e-Newsletter
Post ISCT Review: Find answers to ISCT attendees’ questions, ask your own, and view related ISCT posters. Read more

December 4, 2017
Cook Regentec e-Newsletter
Does Pathogen-Reduced HPL Exist? Find out Dec. 6 at the Cell Therapy Manufacturing & Gene Therapy Congress. Read more

July 17, 2017
Cook Regentec e-Newsletter
8 Ways to Control Your Thawing. Control temperature, safety, consistency, and data logging of your cells. Read more

April 27, 2017
Cook Regentec e-Newsletter
5 Days Until ISCT: EXCLUSIVE PREVIEW of our ISCT featured products & solutions for regenerative medicine therapies. Read more

Connect with us

Stay up-to-date on all of Cook Regentec news and information.

Advancing regenerative medicine therapies

Cook Regentec is focused on developing research and clinical tools to advance regenerative medicine therapies from the lab to the patient. Cook Regentec’s starting range of products includes cellular growth media, solutions for cryopreservation, and medical devices for the delivery of therapeutic agents.

Tools To... build your cell & gene therapies
EXPLORE